A study by the German Low Grade Lymphoma Study Group has shown that rituximab maintenance following salvage with rituximab-containing chemotherapy is the standard of care for advanced-stage refractory or relapsed follicular lymphoma.
Related Articles
Impact Factor
Follicular lymphoma: side-lined drug excites new interest
Senza categoria
Newsround
Impact Factor
Leave a Reply